peptid
basedvaccin
becom
one
wide
investig
prophylact
therapeut
health
care
intervent
varieti
diseas
includ
cancer
howev
lack
safe
highli
effici
adjuv
immun
stimul
regard
biggest
obstacl
vaccin
develop
incorpor
peptid
antigen
nanostructurebas
deliveri
system
recent
shown
overcom
obstacl
nanostructur
often
form
antigen
conjug
molecul
polym
lipid
peptid
help
selfassembl
phenomenon
review
describ
applic
selfassembl
process
product
peptidebas
vaccin
candid
abil
nanostructur
stimul
humor
cellular
immun
respons
stimul
cytotox
lymphocyt
respons
elimin
cell
alreadi
infect
therapeut
vaccin
grow
pharmaceut
sector
sipuleucelt
approv
food
drug
administr
fda
prostat
cancer
talimogen
laherparepvec
tvec
introduc
metastat
melanoma
despit
advantag
vaccin
also
drawback
tradit
vaccin
base
attenu
inactiv
pathogen
may
revert
virul
form
caus
autoimmun
strong
allerg
respons
addit
product
stabil
type
vaccin
often
challeng
subunit
vaccin
contain
small
fragment
whole
pathogen
organ
instanc
recombin
protein
peptid
carbohydr
recombin
proteinbas
vaccin
caus
fewer
advers
effect
difficulti
protein
extract
possibl
contamin
product
signific
disadvantag
recombin
vaccin
also
trigger
undesir
immun
respons
avoid
obstacl
minim
fragment
protein
care
immunolog
inform
peptid
epitop
use
vaccin
design
howev
peptidebas
vaccin
still
achil
heel
peptid
usual
immunogen
therefor
use
immunostimul
agent
adjuv
essenti
success
vaccin
formul
adjuv
compound
abl
evok
enhanc
immun
respons
codeliv
antigen
number
adjuv
alreadi
develop
exampl
freund
adjuv
lipid
cholera
toxin
aluminum
salt
cytokin
liposom
saponin
cpg
oligodeoxynucleotid
howev
immunostimul
properti
adjuv
often
poor
toxic
signific
therefor
suitabl
human
treatment
thu
safer
effici
adjuv
urgent
requir
nanotechnolog
one
quickli
grow
field
scienc
engin
wide
appli
materi
electron
manufactur
agricultur
scienc
chemistri
bioscienc
bioscienc
nanotechnolog
use
creat
sensor
medic
imag
diagnost
tool
drug
deliveri
wide
use
nanostructur
field
nanoparticl
nanoparticl
often
defin
particl
diamet
rang
nm
particl
diamet
within
rang
nm
consid
submicro
particl
howev
follow
common
understand
nanos
rang
nanostructur
articl
defin
nanometers
object
rang
nm
nanoparticl
especi
use
vaccin
design
mani
pathogen
within
nanomet
rang
nanoparticl
usual
taken
effici
antigenpres
cell
apc
apc
key
element
primari
innat
immun
system
respons
trigger
adapt
immun
respons
therefor
nanostructur
often
immunostimul
properti
help
trigger
immun
reaction
antigen
deliv
fig
moreov
surfac
nanostructur
modifi
specif
target
moieti
better
apc
recognit
uptak
two
main
approach
creat
nanostructur
mechan
break
larg
materi
nanostructur
build
nanostructur
basic
segment
often
via
selfassembl
process
first
approach
use
extern
forc
like
grind
mill
high
pressur
break
origin
materi
process
add
addit
complex
produc
nanostructur
harsh
condit
use
break
initi
compon
may
damag
antigen
nanostructur
produc
method
typic
low
load
capac
often
biodegrad
thu
may
accumul
human
tissu
meanwhil
selfassemblybas
strategi
product
nanoparticl
vaccin
overcom
problem
highlight
use
carrierantigen
conjug
form
selfassembl
nanostructur
effect
combin
ration
vaccin
design
format
selfassembl
nanoparticl
carrierantigen
peptid
epitop
conjug
abil
gener
humoralcellular
immun
respons
discuss
fig
extens
review
nonconjug
selfassembl
antigen
carrier
liposom
found
recent
literatur
similarli
viruslik
particl
vlp
form
selfassembl
process
review
extens
recent
literatur
therefor
fig
schemat
represent
selfassembl
peptid
subunit
vaccin
immun
respons
induc
upon
immun
nanostructur
g
zhao
et
al
vaccin
agent
confer
improv
immun
individu
specif
diseas
vaccin
typic
compos
attenu
inactiv
microorgan
virus
fragment
sinc
develop
first
vaccin
two
hundr
year
ago
vaccin
becom
one
popular
intervent
varieti
infecti
diseas
moreov
vaccin
avail
choic
combat
infect
effect
drug
treatment
exist
eg
poliomyel
compar
classic
drug
requir
multipl
dose
longterm
protect
specif
pathogen
diseas
make
vaccin
cost
time
effect
choic
addit
comparison
drug
vaccin
typic
lower
toxic
especi
normal
use
singl
dose
treatment
mass
vaccin
significantli
control
spread
infecti
diseas
classic
vaccin
prophylact
howev
mani
modern
vaccin
design
elimin
exist
diseas
eg
cancer
thu
therapeut
prophylact
vaccin
usual
offer
longterm
protect
infecti
diseas
contrast
prophylact
vaccin
usual
induc
humor
immun
respons
antibodi
product
therapeut
vaccin
design
http
beyond
scope
articl
selfassembl
refer
phenomenon
basic
constitu
arrang
spontan
order
structur
pattern
exampl
selfassembl
found
macroworld
eg
selfassembl
star
galaxi
well
micro
nano
scale
mani
molecul
found
selfassembl
nanoor
microstructur
molecular
selfassembl
defin
spontan
arrang
molecul
noncoval
interact
direct
intern
extern
factor
intern
factor
properti
nanostructur
compon
molecul
instanc
hydrophilichydrophob
ratio
charg
hydrogen
bond
format
molecular
weight
molecular
conform
extern
factor
environment
condit
surround
nanostructur
ph
concentr
temperatur
solvent
incorpor
selfassembl
process
product
drug
vaccin
construct
offer
sever
advantag
firstli
properti
instanc
size
composit
charg
nanostructur
precis
defin
high
batchtobatch
consist
welldefin
physic
chemic
properti
crucial
biomed
applic
nanostructur
secondli
prepar
selfassembl
nanostructur
effici
econom
nanostructur
form
spontan
minim
use
chemic
selfassembl
make
process
environment
friendli
thirdli
nanostructur
form
selfassembl
process
expect
biodegrad
easili
basic
unit
nt
chemic
crosslink
addit
welldefin
properti
nanostructur
materi
make
easier
approv
medic
use
regulatori
bodi
fda
selfassembl
acquir
addit
complex
use
vaccin
design
normal
structur
peptid
sequenc
antigen
modifi
without
affect
immunolog
properti
thu
selfassembl
process
usual
control
carrier
assembl
induc
conjug
antigen
fig
peptid
antigen
often
hydrophil
therefor
hydrophob
moieti
polym
lipid
special
peptid
usual
fill
role
result
amphiphil
conjug
selfassembl
order
nanostructur
polym
alon
conjug
moieti
exhibit
amphiphil
properti
selfassembl
particl
selfassembl
particl
use
vaccin
deliveri
protect
antigen
enzymat
degrad
enhanc
antigen
uptak
apc
may
selfadjuv
properti
remov
potenti
advers
effect
associ
use
classic
adjuv
structur
polym
easili
alter
thu
size
charg
mucoadhes
nanoparticl
vaccin
adjust
nanoparticl
vaccin
selfassembl
polymerantigen
conjug
develop
recent
toth
colleagu
develop
first
selfassembl
tertbutyl
polyacryl
peptid
antigen
conjugatebas
vaccin
polyacryl
dendrit
polym
fig
obtain
via
success
atomtransf
radic
polymer
multipl
copi
hydrophil
b
cell
epitop
kqaedkvkasreakkqvekaleqledkvk
deriv
major
ga
virul
factor
protein
attach
termin
alkyn
hydrophob
dendrim
via
coppercatalyz
azidealkyn
cycloaddit
cuaac
reaction
form
amphiphil
conjug
selfassembl
solvent
exchang
condit
result
nm
particl
narrow
size
distribut
subcutan
immun
nanoparticl
induc
strong
system
humor
immun
respons
mice
titer
specif
immunoglobulin
g
igg
secret
similar
induc
complet
freund
adjuv
cfa
cfa
power
adjuv
often
use
gold
standard
vaccin
develop
process
howev
toxic
human
use
conjug
polym
peptid
crucial
induc
immun
respons
physic
mixtur
polym
antigen
induc
antibodi
product
nanoparticl
also
abl
induc
high
igg
titer
intranas
administr
antibodi
abl
partial
opson
one
common
ga
strain
interestingli
conjug
chosen
peptid
antigen
produc
polymerbas
vaccin
candid
conjug
abl
selfassembl
nanoparticl
system
use
deliv
follow
peptid
antigen
b
cell
epitop
deriv
group
streptococcu
protein
human
papilloma
viru
hpv
protein
epitop
deriv
min
ser
ly
polym
fig
conjug
epitop
conjug
form
larger
nanoparticl
nm
counterpart
larger
particl
induc
significantli
lower
igg
titer
cfaadjuv
control
nm
final
small
librari
polyacryl
investig
upon
conjug
peptid
bear
epitop
pan
dr
epitop
padr
univers
thelper
use
target
immunolog
divers
outbr
human
popul
form
larg
nanoparticl
nm
induc
strong
humor
immun
respons
equipot
cfa
despit
rel
larg
size
particl
antibodi
effici
kill
clinic
ga
isol
opson
experi
thu
polyacrylatepolymerbas
deliveri
system
effect
mean
induc
strong
humor
immun
respons
inbr
outbr
mousel
model
liu
et
al
appli
polyacrylatebas
selfassembl
nanoparticl
deliveri
system
induc
cellular
immun
respons
design
sever
therapeut
vaccin
candid
human
papilloma
viru
hpv
relat
cancer
fig
initi
polyacryl
chosen
polymer
core
qaepdrahynivtfcckcd
epitop
human
papilloma
viru
protein
antigen
epitop
sequenc
contain
cystein
may
form
disulfid
bond
result
uncontrol
aggreg
conjug
therefor
three
modifi
epitop
ser
qaepdrahynivtfssksd
ly
qaepdrahynivtfskkkk
min
qaepdrahynivtf
design
conjug
polym
polymerpeptid
conjug
selfassembl
water
form
small
nanoparticl
nm
ly
big
nanoparticl
nm
ser
microparticl
min
howev
conjug
aggreg
form
microparticl
formul
phosphatebuff
salin
pb
immun
studi
microparticl
test
vivo
tumor
challeng
model
mice
emuls
epitop
incomplet
freund
adjuv
ifa
like
adjuv
montanid
use
posit
control
compound
min
initi
stronger
immun
respons
tumor
growth
slower
mice
vaccin
min
posit
control
min
epitop
effect
tumor
challeng
studi
thu
conjug
polyacryl
polym
vari
level
branch
polymerpeptid
vaccin
candid
abl
selfassembl
microparticl
size
rang
narrow
size
distribut
span
dendrim
highest
level
branch
induc
strongest
antitumor
respons
tumor
challeng
studi
surviv
rate
mice
vaccin
min
min
min
mice
surviv
immun
ifalik
adjuv
importantli
mice
immun
min
surviv
tumor
free
end
experi
conjug
min
also
effici
uptak
apc
stimul
strong
cell
activ
immun
cell
deplet
experi
confirm
cell
crucial
vaccin
anticanc
activ
polym
use
form
selfassembl
nanoparticl
system
perrier
colleagu
conjug
two
differ
length
epitop
gsta
gvtsapdtrpapgstappah
extracellular
variabl
number
tandem
repeat
region
cancerassoci
glycoprotein
poli
nisopropyl
acrylamid
cuaac
reaction
respect
produc
vaccin
candid
vaccin
candid
abl
selfassembl
nm
nm
nanoparticl
respect
howev
efficaci
nanoparticl
confirm
immun
experi
hubbel
cowork
develop
poli
ethylen
glycol
stabil
poli
propylen
sulfid
core
nanoparticl
pegpp
polym
selfassembl
form
nm
nanoparticl
ovalbumin
ova
antigen
conjug
pegpp
nanoparticl
via
disulfid
bond
particl
size
increas
nm
upon
intraderm
immun
vaccin
candid
induc
higher
antibodi
titr
lower
cytokin
product
solubl
antigen
alon
keller
et
al
also
conjug
ova
selfassembl
amphiphil
diblock
copolym
poli
hpmacopyridyl
disulfid
methacrylamid
pdsma
b
paacopoli
dimethylaminoethyl
methacryl
cobutyl
methacryl
bma
form
nm
ph
nanoparticl
case
polym
allow
selfassembl
ova
protein
conjug
particl
via
disulfid
bond
conjug
effici
taken
apc
subcutan
immun
induc
stronger
interferon
gamma
product
correl
cell
activ
physic
mixtur
ova
protein
carrier
although
polym
base
selfassembl
nanostructur
effect
stimul
immun
respons
fulli
defin
length
polym
precis
control
polymer
reaction
disadvantag
regulatori
perspect
may
influenc
size
vaccin
particl
inde
relationship
degre
polymer
size
selfassembl
polym
nanoparticl
report
addit
conjug
polym
specif
epitop
often
produc
product
variabl
degre
substitut
although
nonbiodegrad
polym
form
stabl
nanoparticl
potenti
vivo
toxic
type
materi
must
consid
case
biodegrad
polym
properti
exampl
size
charg
etc
nanovaccin
may
chang
vaccin
reach
target
bodi
thu
vaccin
may
induc
desir
immun
respons
consequ
materi
investig
develop
peptidebas
subunit
vaccin
lipid
one
import
biomolecul
natur
involv
energi
suppli
main
compon
biolog
membran
act
steroid
hormon
enzym
activ
growth
factor
signal
molecul
neural
system
antioxid
live
organ
immun
system
often
play
role
danger
signal
via
activ
toll
like
receptor
tlr
receptor
import
membran
protein
present
surfac
apc
activ
immun
system
respons
foreign
substanc
lipopolysaccharid
lipopeptid
present
membran
microbi
pathogen
except
aluminumand
viru
like
particl
vlp
base
adjuv
adjuv
commerci
vaccin
lipidbas
formul
ie
liposom
sever
lipid
selfassembl
nanoparticl
vaccin
candid
develop
use
amphiphil
properti
lipidpeptid
conjug
one
intens
studi
lipid
deliveri
system
lipidcor
peptid
lcp
first
propos
toth
et
al
fig
system
incorpor
peptid
epitop
branch
moieti
lipid
eg
link
togeth
coval
bond
produc
singlemolecul
vaccin
candid
similar
amphiphil
conjug
lcpbase
vaccin
candid
could
selfassembl
nanoor
microparticl
aqueou
condit
fig
moreov
lipid
moieti
lcp
recogn
thu
selfadjuv
properti
preferenti
taken
apc
induc
strong
immun
respons
incorpor
antigen
exampl
fuaad
et
al
synthes
lcpbase
vaccin
candid
schistosomiasi
carri
epitop
kqaedkvkagptdeiqkinakqledkvk
deriv
cathepsin
hemoglobinas
conjug
selfassembl
nanoparticl
diamet
nm
induc
high
igg
titer
subcutan
inject
similar
trigger
posit
control
cfaadjuv
epitop
moreov
antibodi
neutral
enzymat
activ
schistosoma
cathepsin
lcpbase
system
also
appli
hookworm
vaccin
develop
proteas
chosen
target
antigen
involv
hookworm
digest
system
neutral
b
cell
epitop
agpkaqveaiqki
protein
chosen
peptid
epitop
conjug
lcp
system
sever
lcp
vaccin
candid
synthes
vari
level
branch
epitop
modifi
adopt
helic
conform
compound
abl
selfassembl
nanoparticl
diamet
rang
nm
nm
interestingli
epitop
retain
conform
conjug
lcp
abl
induc
product
antibodi
recogn
parent
protein
result
indic
import
epitop
conform
peptid
subunit
vaccin
develop
importantli
seri
vaccin
candid
target
hookworm
schistosoma
induc
hemolyt
effect
toxic
vitro
even
high
concentr
vaccin
candid
base
lcp
system
streptococcu
pyogen
also
investig
exampl
two
type
epitop
incorpor
lcp
b
cell
epitop
fnbrb
vetedtkepgvlmggqsesveftkdtqtgm
fnbrbt
eftkdtqtgmsgqttpqvetedtkepgvlm
highli
conserv
fibronectinbind
repeat
region
fnbr
sfbi
protein
helic
c
repeat
region
protein
three
monoepitop
vaccin
candid
also
synthes
lcp
bear
fnbrb
fnbrbt
conjug
abl
selfassembl
particl
distinct
size
rang
nanomet
submicronmicroparticl
lcp
bore
hydrophil
epitop
form
small
nanoparticl
incorpor
hydrophob
peptid
lcp
trigger
format
larger
particl
thu
balanc
hydrophil
hydrophob
properti
lcp
compon
crucial
control
size
result
nanoparticl
variat
length
number
posit
lipid
conjug
significantli
influenc
particl
selfassembl
exampl
lipopeptid
carri
short
lipid
adopt
random
coil
secondari
structur
selfassembl
nanoparticl
longer
lipid
induc
format
product
fibril
structur
differ
may
influenc
immunolog
properti
particlebas
vaccin
instanc
size
found
play
import
role
lcpbase
vaccin
administ
intranas
smaller
nanoparticl
nm
taken
effici
apc
strongli
enhanc
apcmatur
gener
robust
immun
respons
comparison
bigger
particl
nm
furthermor
lipopeptid
carri
longer
lipid
induc
stronger
immun
respons
shorter
analogu
lcp
system
also
appli
deliveri
multiepitopebas
polypeptid
semisynthet
vaccin
g
produc
maleimid
conjug
lcp
lipid
moieti
see
fig
obtain
use
simpl
chemic
synthesi
recombin
polypeptid
express
escherichia
coli
recombin
polypeptid
design
linear
combin
multipl
epitop
eight
b
cell
epitop
one
helper
epitop
deriv
protein
lipopolypeptid
selfassembl
nm
diamet
particl
although
vaccin
candid
stimul
immun
respons
recombin
polypeptid
subcutan
inject
mice
igg
titer
sever
epitop
contain
within
lipopolypeptid
weaker
induc
cfaadjuv
polypeptid
disulfid
bond
cystein
present
polypeptid
may
chang
conform
epitop
reduc
epitopespecif
humor
immun
respons
lipid
moieti
also
use
selfassembl
peptid
vaccin
develop
exampl
accardo
et
al
conjug
lipid
epitop
gb
ssiefarl
gd
salledpvg
hsv
envelop
glycoprotein
b
gb
glycoprotein
gd
respect
develop
selfassembl
vaccin
candid
conjug
form
nm
nanoparticl
vaccin
candid
induc
cytokin
product
eg
posit
control
lipopolysaccharid
dipalmitoylsglyceryl
cystein
pam
cy
tripalmitoylsglyceryl
cystein
pam
cy
popular
ligand
vaccin
develop
see
fig
exampl
jackson
cowork
develop
hepat
c
viru
hcv
vaccin
candid
conjug
thelper
cell
epitop
hcv
protein
alydvvtkl
conjug
induc
strong
epitopespecif
cellular
immun
respons
measur
product
wilkinson
et
al
conjug
tumorassoci
epitop
peptid
glycopeptid
produc
vaccin
candid
breast
cancer
compound
selfassembl
nm
particl
stimul
product
antibodi
intraderm
immun
howev
strength
humor
immun
respons
compar
classic
adjuv
system
therefor
efficaci
deliveri
system
could
apprais
tirrel
cowork
incorpor
lipid
build
block
cytotox
cell
epitop
ova
eqlesiinfeklt
develop
selfassembl
selfadjuv
vaccin
deliveri
system
conjug
form
nm
diamet
nm
fiberlik
cylindr
nanoparticl
vaccin
candid
induc
strong
cellular
immun
respons
tumor
challeng
experi
mice
treat
conjug
develop
smaller
tumor
significantli
higher
surviv
rate
immun
emuls
ifa
ova
lipid
also
conjug
ga
b
cell
epitop
qaedkvkqsreakkqvekalkqledkvq
conjug
form
nm
diamet
long
cylindr
nanoparticl
igg
antibodi
titer
induc
vaccin
candid
similar
trigger
epitop
adjuv
ifa
author
suggest
despit
similar
lipid
structur
typic
ligand
ie
immun
respons
induc
lipopeptid
mediat
recent
hussein
conjug
differ
lipid
moieti
hpv
cytotox
lymphocyt
ctl
epitop
qllrrevydfafrdl
min
produc
selfassembl
nanovaccin
see
fig
min
form
nm
nanoparticl
min
form
much
larger
particl
nanoparticl
induc
stronger
cellular
immun
respons
microparticl
interestingli
vaccin
candid
bore
wellknown
receptor
agonist
induc
signific
cellular
immun
respons
min
form
rather
larg
aggreg
particl
therefor
suggest
conjug
poor
aqueou
solubl
key
factor
influenc
vaccin
candid
perform
significantli
vast
number
lipopeptid
report
vaccin
candid
date
howev
abil
form
particl
commonli
explor
although
lipidpeptid
conjug
abl
induc
strong
immun
respons
potenti
toxic
lipopeptid
need
taken
account
therefor
selfassembl
peptid
nanovaccin
consist
peptid
compon
import
altern
contrast
classic
polym
describ
peptidebas
selfassembl
nanostructur
fulli
defin
structur
peptid
heteropolym
compos
amino
acid
typic
unit
polypeptid
similar
protein
usual
sequenc
longer
amino
acid
peptid
longer
amino
acid
form
secondari
structur
like
may
selfassembl
form
nanostructur
develop
modern
chemistri
includ
solid
phase
synthesi
practic
peptid
obtain
synthet
high
puriti
peptid
carrier
selfassembl
properti
conjug
peptid
epitop
result
conjug
may
retain
selfassembl
properti
carrier
therefor
form
nanostructur
aqueou
condit
lustig
burkhard
cowork
use
silico
model
design
helic
selfassembl
polypeptid
sap
demlrelqetnaalqdvrellrqqvkqitflkcllmg
grllcrleelerrleelerrleelerr
selfassembl
regular
polyhedr
nanoparticl
fig
sever
vaccin
candid
produc
base
peptid
carrier
deriv
exampl
vaccin
candid
obtain
conjug
peptid
carrier
b
cell
epitop
sever
acut
respiratori
syndrom
sar
b
spike
protein
selfassembl
dialysi
refold
buffer
diamet
nanoparticl
approxim
nm
sap
alon
form
smaller
nanoparticl
nm
mice
immun
produc
antibodi
high
bind
affin
nativ
protein
confirm
deliveri
system
present
epitop
desir
conform
sap
strategi
also
use
develop
malaria
vaccin
tandem
repeat
b
cell
immunodomin
repeat
epitop
dppppnpn
malaria
plasmodium
berghei
circumsporozoit
protein
pbcsp
gene
incorpor
sap
gene
vaccin
candid
call
produc
express
escherichia
coli
vaccin
candid
induc
strong
immun
respons
incorpor
b
cell
epitop
mice
surviv
doubl
challeng
live
sporozoit
receiv
three
dose
sap
deriv
selfassembl
nanoparticl
also
appli
design
vaccin
human
immunodefici
viru
hiv
selfassembl
polypeptid
consist
two
coval
link
peptid
domain
deriv
sap
carrier
peptid
conjug
membran
proxim
extern
region
protein
conjug
form
nm
nanoparticl
intraperiton
immun
conjug
ifa
intraderm
vaccin
without
adjuv
perform
outbr
spraguedawley
rat
sap
analogu
stimul
humor
immun
incorpor
antigen
howev
antibodi
abl
neutral
protein
abil
peptid
adopt
conform
form
fiber
wellknown
natur
phenomenon
exampl
amyloid
peptid
involv
alzheim
diseas
spontan
form
fibril
human
brain
waku
et
al
attempt
develop
novel
vaccin
candid
base
selfassembl
nanofib
fig
peptid
form
fvifld
conjug
peptid
epitop
ova
siinfekl
highli
hydrophil
cellpenetr
peptid
tat
rkkrrqrrr
form
linear
oligopeptid
incub
mm
salin
compound
form
nanofib
micrometr
long
unabl
selfassembl
incub
water
fiber
trim
nm
length
extrus
membran
filter
pore
diamet
width
height
nanofib
estim
tem
atomicforc
microscopi
afm
nm
nm
respect
nanofib
taken
effici
murin
macrophagelik
cell
ova
tat
ova
peptid
howev
report
whether
system
could
induc
immun
respons
vivo
collier
cowork
examin
anoth
fibril
peptid
qqkfqfqfeqq
abil
serv
carrier
ova
isqavhaahaeineagr
peptid
conjug
ova
epitop
serglysergli
spacer
conjug
selfassembl
nanofib
aqueou
environ
contain
salt
unbranch
nanofib
approxim
nm
wide
micron
scale
length
titer
igg
induc
nanofib
vaccin
emuls
cfa
ova
compar
unconjug
physic
mixtur
peptid
induc
antibodi
product
howev
dose
vaccin
candid
around
mg
per
mous
per
inject
use
immun
studi
higher
typic
dose
use
selfassembl
vaccin
deliveri
system
mg
per
mous
per
inject
nanofib
form
peptid
induc
cytotox
inflamm
contrast
alum
adjuv
imject
alum
examin
macrophag
cell
line
cell
upon
immun
titer
ova
specif
antibodi
high
induc
emuls
ova
epitop
cfa
significantli
higher
alum
adjuv
ova
epitop
fibril
peptid
conjug
malaria
b
cell
epitop
nanp
nanpnanpnanp
deriv
circumsporozoit
protein
plasmodium
falciparum
nanp
conjug
selfassembl
nanofib
conjug
induc
humor
immun
respons
plasmodium
falciparum
circumsporozoit
protein
deliv
subcutan
mous
model
anoth
peptid
spontan
assembl
nanofib
fkfefkf
also
investig
combin
ova
peptid
compar
conjug
signific
differ
immun
respons
observ
suggest
nanofib
format
respons
adjuv
activ
specif
carrierpeptid
sequenc
azmi
et
al
also
tri
develop
peptidebas
selfassembl
nanofib
vaccin
ga
infect
ga
epitop
coval
link
via
spacer
howev
result
compound
form
nanoparticl
instead
expect
nanofib
induc
signific
igg
product
mice
compar
pb
poor
immunogen
construct
might
relat
low
dose
use
immun
studi
comparison
typic
use
conjug
interestingli
two
copi
lipid
moieti
conjug
alon
form
nanoparticl
dose
induc
high
antibodi
titer
similar
trigger
emulsifi
cfa
therefor
fibril
peptid
selfadjuv
abil
weaker
lipid
recent
amino
acid
also
suggest
deliveri
platform
vaccin
demonstr
b
cell
epitop
deriv
ga
protein
form
water
solubl
molecul
conjug
valinerich
isopeptid
depsipeptid
howev
upon
chang
ph
acid
neutral
isopeptid
undergo
acyl
migrat
reaction
form
linear
parent
peptid
peptid
adopt
conform
promptli
aggreg
fibril
immunogen
properti
fibril
report
yet
summari
one
preval
secondari
structur
protein
conform
thu
nanofib
approach
seem
natur
safe
selfassembl
strategi
thu
investig
role
nanofibr
vaccin
develop
area
grow
interest
selfassembl
becom
popular
method
produc
nanostructurebas
vaccin
nanoparticl
built
polym
lipid
wide
use
antigen
deliveri
howev
potenti
use
nanofib
antigen
carrier
neglect
low
toxic
high
biocompat
selfassembl
materi
make
valuabl
vaccin
formul
classic
adjuv
selfassembl
induc
often
recogn
receptor
immun
cell
therefor
nanostructur
display
selfadjuv
properti
remov
need
use
toxic
adjuv
moreov
selfassembl
antigencarri
conjug
usual
despit
advantag
selfassembl
vaccin
drawback
may
influenc
chanc
commerci
case
polymerbas
selfassembl
vaccin
polymer
reaction
use
product
form
singl
product
defin
molecular
weight
polymerbas
particl
also
poor
biodegrad
thu
care
polym
select
requir
avoid
advers
effect
associ
polym
accumul
tissu
optim
balanc
biodegrad
stabil
must
found
polym
degrad
quickli
may
caus
nanovaccin
chang
properti
eg
size
reach
destin
lymph
node
apc
etc
lipidbas
selfassembl
nanostructur
also
face
obstacl
particularli
toxic
membran
disrupt
poor
induct
cellular
immun
one
effici
lipid
adjuv
lipid
highli
toxic
therefor
hemolyt
toxic
properti
lipopeptid
must
examin
fortun
sever
lipopeptid
highli
immunogen
nontox
eg
lcp
system
although
lipopeptid
rare
induc
strong
cellular
immun
respons
one
possibl
solut
incorpor
apctarget
moieti
selfassembl
system
allow
better
antigen
crosspresent
addit
lipid
normal
racem
eg
therefor
form
diastereomer
mixtur
conjug
peptid
diastereoisom
may
differ
safeti
activ
profil
disadvantag
peptidebas
carrier
low
immunogen
form
conjug
thu
high
dose
requir
stimul
desir
immun
respons
might
potenti
obstacl
develop
peptidecarrierbas
selfassembl
nanostructur
limit
understand
interact
nanostructur
vaccin
immun
cell
receptor
hinder
develop
selfassembl
nanostructur
vaccin
investig
conjug
stabil
differ
condit
apc
uptak
target
cell
activ
dc
matur
cytokin
profil
recognit
conjug
receptor
human
anim
tissu
task
futur
howev
area
understood
selfassembl
nanostructur
vaccin
develop
exploit
opportun
major
selfassembl
conjug
monoval
carri
singl
epitopeantigen
therefor
induc
immun
respons
one
target
subtyp
pathogen
selfassembl
process
offer
critic
advantag
sever
differ
build
block
bear
differ
epitop
mix
selfassembl
singl
multiantigen
nanostructur
overal
applic
selfassembl
strategi
develop
peptidebas
vaccin
demonstr
polym
lipidand
peptidebas
deliveri
system
overcom
low
immunogen
peptid
antigen
without
caus
advers
effect
thu
use
selfadjuv
particl
could
elimin
requir
toxic
adjuv
vaccin
design
although
peptid
subunit
vaccin
commerci
avail
expect
near
futur
multival
selfassembl
nanoparticl
higher
immun
efficaci
lower
toxic
appear
market
